Bryn Mawr College Physics Colloquium

Proton Therapy at the University of Pennsylvania: Clinic, Research and Education

Prof. Stephen Avery
Assistant Professor of Radiation Oncology
Director of Master of Medical Physics Program
University of Pennsylvania

Monday 30 September 2013

 

Abstract: In the United States and other countries around the world, proton therapy for treatment of cancer is increasingly becoming an accepted modality in radiation oncology because of its ability to deposit highly conformal dose to the tumor while sparing healthy tissue neighboring the tumor site.  In proton therapy, determining the distal edge of the Bragg peak is often the most uncertain parameter.  The mean range of a given beam in a given material can only be predicted to an accuracy of 1% to 2%.  I will give share our experience treating with protons at the University of Pennsylvania which will include: 1) an overview of our proton delivery system, 2) comparing treatment modalities and 3) a description of our patient pool to date.  We have taken initiative steps to be a global leader in education and research through a diverse portfolio of programs that develop future leaders in proton therapy.  I will discuss innovative programs that leverage institutional strengths to improve cancer care.